Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective trial of abiraterone acetate plus prednisone in Black and White men with metastatic castrate-resistant prostate cancer.
George DJ, Halabi S, Heath EI, Sartor AO, Sonpavde GP, Das D, Bitting RL, Berry W, Healy P, Anand M, Winters C, Riggan C, Kephart J, Wilder R, Shobe K, Rasmussen J, Milowsky MI, Fleming MT, Bearden J, Goodman M, Zhang T, Harrison MR, McNamara M, Zhang D, LaCroix BL, Kittles RA, Patierno BM, Sibley AB, Patierno SR, Owzar K, Hyslop T, Freedman JA, Armstrong AJ. George DJ, et al. Among authors: kephart j. Cancer. 2021 Aug 15;127(16):2954-2965. doi: 10.1002/cncr.33589. Epub 2021 May 5. Cancer. 2021. PMID: 33951180 Free PMC article.
Phase Ib Trial of Cabazitaxel and Tasquinimod in Men With Heavily Pretreated Metastatic Castration Resistant Prostate Cancer (mCRPC): The CATCH Trial.
Armstrong AJ, Humeniuk MS, Healy P, Szmulewitz R, Winters C, Kephart J, Harrison MR, Martinez E, Mundy K, Halabi S, George D. Armstrong AJ, et al. Among authors: kephart j. Prostate. 2017 Mar;77(4):385-395. doi: 10.1002/pros.23277. Epub 2016 Nov 16. Prostate. 2017. PMID: 27862097 Free PMC article. Clinical Trial.
Phase II trial of the PI3 kinase inhibitor buparlisib (BKM-120) with or without enzalutamide in men with metastatic castration resistant prostate cancer.
Armstrong AJ, Halabi S, Healy P, Alumkal JJ, Winters C, Kephart J, Bitting RL, Hobbs C, Soleau CF, Beer TM, Slottke R, Mundy K, Yu EY, George DJ. Armstrong AJ, et al. Among authors: kephart j. Eur J Cancer. 2017 Aug;81:228-236. doi: 10.1016/j.ejca.2017.02.030. Epub 2017 May 11. Eur J Cancer. 2017. PMID: 28502694 Free PMC article. Clinical Trial.
Prospective clinical trial of disulfiram plus copper in men with metastatic castration-resistant prostate cancer.
Zhang T, Kephart J, Bronson E, Anand M, Daly C, Spasojevic I, Bakthavatsalam S, Franz K, Berg H, Karachaliou GS, James OG, Howard L, Halabi S, Harrison MR, Armstrong AJ, George DJ. Zhang T, et al. Among authors: kephart j. Prostate. 2022 May;82(7):858-866. doi: 10.1002/pros.24329. Epub 2022 Mar 14. Prostate. 2022. PMID: 35286730 Clinical Trial.
Exploring Charge Redistribution at the Cu/Co6Se8 Interface.
Krajewski SM, Love RJ Jr, Kephart JA, Boggiano AC, La Pierre HS, Kaminsky W, Velian A. Krajewski SM, et al. Among authors: kephart ja. Inorg Chem. 2024 Oct 28;63(43):20388-20397. doi: 10.1021/acs.inorgchem.4c02639. Epub 2024 Oct 21. Inorg Chem. 2024. PMID: 39431559
Social disparities in flood exposure and associations with the urban environment in 44,698 neighborhoods in 276 cities in eight Latin American countries.
Kephart JL, Bilal U, Gouveia N, Sarmiento OL, Shingara E, Moreno KR, Bakhtsiyarava M, Rodriguez JP, Ayala S, Carrasco-Escobar G, Diez Roux AV; SALURBAL-Climate Project. Kephart JL, et al. medRxiv [Preprint]. 2024 Jul 3:2024.07.02.24309839. doi: 10.1101/2024.07.02.24309839. medRxiv. 2024. PMID: 39006415 Free PMC article. Preprint.
82 results